GeneBioTech (Korea) Price on December 19, 2024

086060 Stock  KRW 3,485  10.00  0.29%   
If you're considering investing in GeneBioTech Stock, it is important to understand the factors that can impact its price. As of today, the current price of GeneBioTech stands at 3,485, as last reported on the 11th of January 2025, with the highest price reaching 3,490 and the lowest price hitting 3,430 during the day. At this point, GeneBioTech is very steady. GeneBioTech holds Efficiency (Sharpe) Ratio of 0.0141, which attests that the entity had a 0.0141% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for GeneBioTech, which you can use to evaluate the volatility of the firm. Please check out GeneBioTech's Market Risk Adjusted Performance of (0.08), standard deviation of 1.79, and Risk Adjusted Performance of 0.0027 to validate if the risk estimate we provide is consistent with the expected return of 0.0259%.
  
GeneBioTech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0141

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns086060

Estimated Market Risk

 1.84
  actual daily
16
84% of assets are more volatile

Expected Return

 0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
1
99% of assets perform better
Based on monthly moving average GeneBioTech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeneBioTech by adding it to a well-diversified portfolio.

GeneBioTech Valuation on December 19, 2024

It is possible to determine the worth of GeneBioTech on a given historical date. On December 19, 2024 GeneBioTech was worth 3360.0 at the beginning of the trading date compared to the closed value of 3410.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GeneBioTech stock. Still, in general, we apply an absolute valuation method to find GeneBioTech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GeneBioTech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GeneBioTech's related companies.
 Open High Low Close Volume
  3,410    3,430    3,340    3,410    40,018  
12/19/2024
  3,360    3,430    3,340    3,410    35,752  
  3,375    3,405    3,270    3,270    56,855  
Backtest GeneBioTech  |  GeneBioTech History  |  GeneBioTech Valuation   PreviousNext  
Open Value
3360.0
3410.0
Closing Value
3,366
Upside

GeneBioTech Trading Date Momentum on December 19, 2024

On December 20 2024 GeneBioTech Co was traded for  3,270  at the closing time. The highest price during the trading period was 3,405  and the lowest recorded bid was listed for  3,270 . The volume for the day was 56.9 K. This history from December 20, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 4.11% . The overall trading delta to the current price is 6.30% .

GeneBioTech Fundamentals Correlations and Trends

By evaluating GeneBioTech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GeneBioTech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GeneBioTech financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About GeneBioTech Stock history

GeneBioTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GeneBioTech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GeneBioTech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GeneBioTech stock prices may prove useful in developing a viable investing in GeneBioTech
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. The company was founded in 1984 and is headquartered in Gongju, South Korea. GeneBioTech is traded on Korean Securities Dealers Automated Quotations in South Korea.

GeneBioTech Stock Technical Analysis

GeneBioTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GeneBioTech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GeneBioTech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

GeneBioTech Period Price Range

Low
January 11, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

GeneBioTech Co cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

GeneBioTech January 11, 2025 Market Strength

Market strength indicators help investors to evaluate how GeneBioTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeneBioTech shares will generate the highest return on investment. By undertsting and applying GeneBioTech stock market strength indicators, traders can identify GeneBioTech Co entry and exit signals to maximize returns

GeneBioTech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GeneBioTech's price direction in advance. Along with the technical and fundamental analysis of GeneBioTech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GeneBioTech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for GeneBioTech Stock analysis

When running GeneBioTech's price analysis, check to measure GeneBioTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneBioTech is operating at the current time. Most of GeneBioTech's value examination focuses on studying past and present price action to predict the probability of GeneBioTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneBioTech's price. Additionally, you may evaluate how the addition of GeneBioTech to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world